Back
Emergent BioSolutions 10K Form
Sell
30
EBS
Emergent BioSolutions
Last Price:
$8.14
Seasonality Move:
-0.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-12-11 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-08-09 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2023-05-10 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2022-11-09 | 10Q | EBS/Emergent BioSolutions Quarterly |
| 2022-08-02 | 10Q | EBS/Emergent BioSolutions Quarterly |
Receive EBS News And Ratings
See the #1 stock for the next 7 days that we like better than EBS
EBS Financial Statistics
Sales & Book Value
| Annual Sales: | $1B |
|---|---|
| Cash Flow: | $147.9M |
| Price / Cash Flow: | 3.14 |
| Annual Sales: | $9.40 |
| Price / Book: | 0.87 |
Profitability
| EPS (TTM): | -4.10000 |
|---|---|
| Net Income (TTM): | $-208.8M |
| Gross Margin: | $317.6M |
| Return on Equity: | -35.94% |
| Return on Assets: | -12.27% |
Emergent BioSolutions Earnings Forecast
Key Emergent BioSolutions Financial Ratios
-
The Gross Profit Margin over the past 22 years for EBS is 31.05%.
-
The Selling, General & Administrative Expenses for EBS have been equal to 36.01% of Gross Profit Margin.
-
The Research & Development expenses have been 10.89% of Revenue.
-
The Interest Expense is -11.56% of Operating Income.
-
The Net Earning history of EBS is -74.34% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 12 years.
Emergent BioSolutions Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | EBS |
| CUSIP: | 29089Q |
| Website: | emergentbiosolutions.com |
Debt
| Debt-to-Equity Ratio: | 1.3 |
|---|---|
| Current Ratio: | 2.88 |
| Quick Ratio: | 1.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 3.95 |
EBS Technical Analysis vs Fundamental Analysis
Sell
30
Emergent BioSolutions (EBS)
is a Sell
Is Emergent BioSolutions a Buy or a Sell?
-
Emergent BioSolutions stock is rated a SellThe current Emergent BioSolutions [EBS] share price is $8.15. The Score for EBS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.